Inventor · disambiguated record
Roy A. Black
Also filed as: BLACK ROY A
15 granted patents·11 pending applications·467 citations·filing 1994–2014
94Inventor score
Top patents by PatentIndex Score
26 records- 0195US7695948B2Antibodies that bind TNF-α converting enzymeIMMUNEX CORP·Filed 2007·Granted Apr 13, 2010·21 cites·6 claims
- 0293US5629285AInhibitors of TNF-α secretionIMMUNEX CORP·Filed 1996·Granted May 13, 1997·113 cites·19 claims
- 0391US7199224B2Antibodies that bind TNF-α converting enzymeIMMUNEX CORP·Filed 2003·Granted Apr 3, 2007·19 cites·13 claims
- 0490US7074408B2Use of integrin antagonists to inhibit angiogenesisIMMUNEX CORP·Filed 2001·Granted Jul 11, 2006·49 cites·29 claims
- 0585US5594106AInhibitors of TNF-α secretionIMMUNEX CORP·Filed 1994·Granted Jan 14, 1997·60 cites·17 claims
- 0684US5416013AInterleukin 1β protease and interleukin 1β protease inhibitorsSTERLING WINTHROP INC·Filed 1994·Granted May 16, 1995·77 cites·3 claims
- 0781US5830742ATNF-α converting enzymeIMMUNEX CORP·Filed 1996·Granted Nov 3, 1998·42 cites·15 claims
- 0880US6013466ATNF-α converting enzymeIMMUNEX CORP·Filed 1998·Granted Jan 11, 2000·29 cites·34 claims
- 0978US6995141B1Interleukin 1β protease and interleukin 1β protease inhibitorsVERTEX PHARMA·Filed 2000·Granted Feb 7, 2006·6 cites·17 claims
- 1075US6406901B1TNF-a converting enzymeIMMUNEX CORP·Filed 2000·Granted Jun 18, 2002·2 cites·36 claims
- 1170US5756465AInterleukin 1β protease and interleukin 1β protease inhibitorsSANOFI SA·Filed 1995·Granted May 26, 1998·25 cites·11 claims
- 1269US6136787AInterleukin 1β protease and interleukin 1β protease inhibitorsVERTEX PHARMA·Filed 1998·Granted Oct 24, 2000·22 cites·30 claims
- 1359US2006188474A1Interleukin 1beta protease and interleukin 1beta protease inhibitorsVERTEX PHARMA·Filed 2005·Application pending·0 cites
- 1458US6555354B2TNF-α converting enzymeIMMUNEX CORP·Filed 2000·Granted Apr 29, 2003·0 cites·22 claims
- 1558US6406877B2TNF-α converting enzymeIMMUNEX CORP·Filed 2000·Granted Jun 18, 2002·0 cites·33 claims
- 1655US2004265983A1Crystalline TNF-alpha-converting enzyme and uses thereofIMMUNEX CORP MAX PLANCK I FOR·Filed 2004·Application pending·0 cites
- 1753US2014228540A1Polypeptides that bind tissue inhibitor of metalloproteinase type three (timp-3), compositions and methodsAMGEN INC·Filed 2014·Application pending·0 cites
- 1853US2009247605A1Treating diseases mediated by metalloprotease-shed proteinsIMMUNEX CORP·Filed 2007·Application pending·0 cites
- 1952US2006292144A1Human disintegrin proteinIMMUNEX CORP·Filed 2006·Application pending·0 cites
- 2050US2006177443A1Integrin antagonistsIMMUNEX CORP·Filed 2006·Application pending·0 cites
- 2148US2003004651A1Crystalline TNF-alpha-converting enzyme and uses thereofFiled 2001·Application pending·0 cites
- 2246US2003108959A1Treating diseases mediated by metalloprotease-shed proteinsFiled 2002·Application pending·0 cites
- 2345US2012231013A1Polypeptides that bind tissue inhibitor of metalloproteinase type three (timp-3), compositions and methodsBLACK ROY A·Filed 2010·Application pending·0 cites
- 2443US2004091473A1Metalloproteinase-disintegrin polypeptides and methods of making and use thereofFiled 2001·Application pending·0 cites
- 2542US2004047854A1Human disintegrin proteinFiled 2001·Application pending·0 cites
- 2636US6842704B2Crystalline TNF-α-converting enzyme and uses thereofIMMUNEX CORP·Filed 1999·Granted Jan 11, 2005·2 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Roy A. Black files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →